Pinatuzumab Vedotin

Pinatuzumab Vedotin Uses, Dosage, Side Effects, Food Interaction and all others data.

Pinatuzumab Vedotin is under investigation in clinical trial NCT01691898 (A Study of Pinatuzumab Vedotin (DCDT2980S) Combined With Rituximab or Polatuzumab Vedotin (DCDS4501A) Combined With Rituximab or Obinutuzumab in Participants With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)).

Trade Name Pinatuzumab Vedotin
Generic Pinatuzumab vedotin
Pinatuzumab vedotin Other Names DCDT2980S, Pinatuzumab vedotin
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
Pinatuzumab Vedotin
Pinatuzumab Vedotin

Innovators Monograph

You find simplified version here Pinatuzumab Vedotin

*** Taking medicines without doctor's advice can cause long-term problems.
Share